Related Experiment Video
Updated: Feb 27, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
A DAG-based comparison of interventional effect underestimation between composite endpoint and multi-state analysis
Antje Jahn-Eimermacher1, Katharina Ingel2, Stella Preussler2
1Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center Johannes Gutenberg-University Mainz, Obere Zahlbacher Str. 69, Mainz, 55131, Germany. jahna@uni-mainz.de.
Insights
Analyzing recurrent events in cardiovascular trials, this study shows that including multiple patient episodes, not just the first, reduces bias in treatment effect estimates. This approach enhances statistical power and interpretability for composite endpoints.
Area of Science:
- Cardiovascular clinical trials
- Biostatistics
- Health research methodology
Background:
- Composite endpoints (hospital admissions, death) are key in cardiovascular trials.
- Cox proportional hazards models for time to first event are standard but debated for recurrent events.
- Potential biases of analyzing only first events are often overlooked.
Purpose of the Study:
- Investigate bias in treatment effect estimates when considering first vs. multiple events.
- Utilize directed acyclic graphs (DAGs) and simulation studies for bias analysis.
- Motivated by a heart failure randomized controlled trial.
Main Methods:
- Directed acyclic graphs (DAGs) to identify bias sources.
- Simplified examples and simulation studies to investigate bias.
- Comparison of first-event-only analysis versus recurrent event analysis.
Main Results:
- Cox models restricting to first events are prone to selection and direct effect bias, causing underestimation.
- Incorporating recurrent events reduces these biases.
- Proportional hazards-based multi-state models decrease bias and increase power for recurrent composite endpoints.
Conclusions:
- Including multiple episodes per individual in primary analysis reduces bias in treatment effect estimates.
- Findings support moving beyond the first-event-only paradigm.
- This approach enhances information use and interpretability in cardiovascular research.
Background:
Composite endpoints comprising hospital admissions and death are the primary outcome in many cardiovascular clinical trials. For statistical analysis, a Cox proportional hazards model for the time to first event is commonly applied. There is an ongoing debate on whether multiple episodes per individual should be incorporated into the primary analysis. While the advantages in terms of power are readily apparent, potential biases have been mostly overlooked so far.
Methods:
Motivated by a randomized controlled clinical trial in heart failure patients, we use directed acyclic graphs (DAG) to investigate potential sources of bias in treatment effect estimates, depending on whether only the first or multiple episodes are considered. The biases first are explained in simplified examples and then more thoroughly investigated in simulation studies that mimic realistic patterns.
Results:
Particularly the Cox model is prone to potentially severe selection bias and direct effect bias, resulting in underestimation when restricting the analysis to first events. We find that both kinds of bias can simultaneously be reduced by adequately incorporating recurrent events into the analysis model. Correspondingly, we point out appropriate proportional hazards-based multi-state models for decreasing bias and increasing power when analyzing multiple-episode composite endpoints in randomized clinical trials.
Conclusions:
Incorporating multiple episodes per individual into the primary analysis can reduce the bias of a treatment's total effect estimate. Our findings will help to move beyond the paradigm of considering first events only for approaches that use more information from the trial and augment interpretability, as has been called for in cardiovascular research.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
Effects of EDTA on End-Point Detection Methods
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...